Silence Therapeutics (SLN) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Silence Therapeutics

    NASDAQ: SLN · Real-Time Price · USD
    5.54
    0.54 (10.80%)
    At close: Sep 26, 2025, 3:59 PM
    5.54
    0.00%
    After-hours: Sep 26, 2025, 06:39 PM EDT

    Silence Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 121.33M 54.03M 54.82M 73.54M
    Short-Term Investments
    		 26M n/a 16.33M n/a
    Long-Term Investments
    		 n/a 284K 284K 301K
    Other Long-Term Assets
    		 3.59M 2.58M -10.81M -9.86M
    Receivables
    		 26.91M 228K 17.34M 8.49M
    Inventory
    		 n/a n/a -16.43M n/a
    Other Current Assets
    		 n/a n/a n/a n/a
    Total Current Assets
    		 187.37M 81.02M 96.69M 86.33M
    Property-Plant & Equipment
    		 1.98M 1.81M 2.2M 1.94M
    Goodwill & Intangibles
    		 9.7M 8.12M 8.33M 7.62M
    Total Long-Term Assets
    		 15.27M 12.8M 10.81M 9.86M
    Total Assets
    		 202.63M 93.82M 107.5M 96.19M
    Account Payables
    		 3.7M 2.63M 3.19M 4.07M
    Deferred Revenue
    		 306K n/a 8.86M 4.25M
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 3.44M 6.11M 589K 185K
    Total Current Liabilities
    		 16.82M 17.77M 21.94M 15.17M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 51.79M 59M 63.48M 72.5M
    Total Liabilities
    		 68.61M 76.77M 85.43M 87.67M
    Total Debt
    		 117K 272K 446K 137K
    Book Value
    		 134.02M 17.05M 22.07M 8.53M
    Book Value Per Share
    		 2.84 0.46 0.69 0.29
    Common Stock
    		 10.29M 5.94M 5.39M 4.49M
    Retained Earnings
    		 -474.04M -304.61M -263.26M -222.97M
    Comprehensive Income
    		 -11.78M 64.27M 24.33M 23.79M
    Shareholders Equity
    		 134.02M 17.05M 22.07M 8.53M
    Total Investments
    		 26M 284K 16.61M 301K

    Add to Watchlist